Last updated on December 2009

Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Autosomal Dominant | Polycystic | Kidney
  • Age: Between 20 - 60 Years
  • Gender: Male or Female
  • Other:
    ADPKD patients
    Blood pressure measured at out-patient setting is above 120/80 mmHg
    Age between 20 and 60 years old
    eGFR more than 30 ml/min/1.73m2
    Patients give informed consent

You may not be eligible for this study if the following are true:

  • Patients with severe cardiovascular and hepatic disorders
    Patients with complications of central nervous vascular disorders
    Women who are breast feeding and females of childbearing potential who are not using
    acceptable contraceptive methods
    Patients currently engaging in other experimental protocol
    Patients with intracranial aneurysma
    Patients who must use diuretics
    Allergic patients to Candesartan or Cilnidipine
    Patients whose hypertension is not controlled by medication of this protocol

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.